IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1
Authors
Keywords
-
Journal
eLife
Volume 6, Issue -, Pages -
Publisher
eLife Sciences Organisation, Ltd.
Online
2017-07-28
DOI
10.7554/elife.27155
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- From obesity to diabetes and cancer: epidemiological links and role of therapies
- (2016) Custodia García-Jiménez et al. BRITISH JOURNAL OF CANCER
- The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
- (2016) T.F. Sumter et al. CURRENT MOLECULAR MEDICINE
- IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer
- (2016) Nils Degrauwe et al. GENES & DEVELOPMENT
- Type 2 diabetes: genetic data sharing to advance complex disease research
- (2016) Jason Flannick et al. NATURE REVIEWS GENETICS
- DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up
- (2016) Elisabetta Bigagli et al. CELLULAR ONCOLOGY
- IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells
- (2016) Janani Panneerselvam et al. Oncotarget
- The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing
- (2016) Nils Degrauwe et al. Cell Reports
- Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway
- (2015) Qingchun Mu et al. CANCER BIOLOGY & THERAPY
- IGF2BP2/IMP2-Deficient Mice Resist Obesity through Enhanced Translation of Ucp1 mRNA and Other mRNAs Encoding Mitochondrial Proteins
- (2015) Ning Dai et al. Cell Metabolism
- IGFBP-2: The dark horse in metabolism and cancer
- (2015) V.C. Russo et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IGF2 signaling and regulation in cancer
- (2015) Jurriaan Brouwer-Visser et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The Coordinate Cellular Response to Insulin-like Growth Factor-I (IGF-I) and Insulin-like Growth Factor-binding Protein-2 (IGFBP-2) Is Regulated through Vimentin Binding to Receptor Tyrosine Phosphatase β (RPTPβ)
- (2015) Xinchun Shen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression ofIGF2mRNA-Binding Protein 2 (IMP2/p62) as a Feature of Basal-like Breast Cancer Correlates with Short Survival
- (2015) A. Barghash et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway
- (2015) F-y Liu et al. Cell Death & Disease
- IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype
- (2015) S M Kessler et al. Cell Death & Disease
- p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer
- (2015) Yang Li et al. Oncotarget
- IGF-Binding Protein 2 – Oncogene or Tumor Suppressor?
- (2015) Adam Pickard et al. Frontiers in Endocrinology
- MultiNotch MS3 Enables Accurate, Sensitive, and Multiplexed Detection of Differential Expression across Cancer Cell Line Proteomes
- (2014) Graeme C. McAlister et al. ANALYTICAL CHEMISTRY
- Quantitative Temporal Viromics: An Approach to Investigate Host-Pathogen Interaction
- (2014) Michael P. Weekes et al. CELL
- VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival
- (2014) Ben Davidson et al. HUMAN PATHOLOGY
- The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer
- (2014) Marcell Lederer et al. SEMINARS IN CANCER BIOLOGY
- IGF2 and cancer
- (2013) Callum Livingstone ENDOCRINE-RELATED CANCER
- mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblasts
- (2013) N. Dai et al. GENES & DEVELOPMENT
- IMP2 regulates differentiation potentials of mouse neocortical neural precursor cells
- (2013) Yuki Fujii et al. GENES TO CELLS
- IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling
- (2012) Sonja M. Kessler et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
- (2012) Jessica L. Bell et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- p21WAF1 and tumourigenesis
- (2012) Noel A. Warfel et al. CURRENT OPINION IN ONCOLOGY
- An HMGA2-IGF2BP2 Axis Regulates Myoblast Proliferation and Myogenesis
- (2012) Zhizhong Li et al. DEVELOPMENTAL CELL
- Response to Comment on: Marquez et al. Low-Frequency Variants in HMGA1 Are Not Associated With Type 2 Diabetes Risk. Diabetes 2012;61:524-530
- (2012) P. Froguel et al. DIABETES
- Regulation of insulin and type 1 insulin-like growth factor signaling and action by the Grb10/14 and SH2B1/B2 adaptor proteins
- (2012) Bernard Desbuquois et al. FEBS Journal
- Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells
- (2012) M. Janiszewska et al. GENES & DEVELOPMENT
- The decline and fall of the IGF-I receptor
- (2012) Renato Baserga JOURNAL OF CELLULAR PHYSIOLOGY
- The HMGA1-IGF-I/IGFBP System: A Novel Pathway for Modulating Glucose Uptake
- (2012) Stefania Iiritano et al. MOLECULAR ENDOCRINOLOGY
- Low-Frequency Variants in HMGA1 Are Not Associated With Type 2 Diabetes Risk
- (2011) M. Marquez et al. DIABETES
- mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry
- (2011) N. Dai et al. GENES & DEVELOPMENT
- Functional Variants of the HMGA1 Gene and Type 2 Diabetes Mellitus
- (2011) Eusebio Chiefari JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells
- (2011) Yunzhi Zhang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The insulin resistance Grb14 adaptor protein promotes thyroid cancer ret signaling and progression
- (2011) K Balogh et al. ONCOGENE
- HMGA and Cancer
- (2010) Monica Fedele et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling
- (2010) Q. W-L. Wong et al. CLINICAL CANCER RESEARCH
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene
- (2010) Aurora Aiello et al. EUROPEAN JOURNAL OF CANCER
- Role of the RNA-Binding Protein IMP-2 in Muscle Cell Motility
- (2010) S. Boudoukha et al. MOLECULAR AND CELLULAR BIOLOGY
- Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy
- (2010) D. B. Ulanet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- IGFBP-2 overexpression reduces the appearance of dysplastic aberrant crypt foci and inhibits growth of adenomas in chemically induced colorectal carcinogenesis
- (2008) Daniela Diehl et al. INTERNATIONAL JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started